Mengshen Wang

699 total citations
18 papers, 492 citations indexed

About

Mengshen Wang is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Mengshen Wang has authored 18 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cancer Research, 7 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Mengshen Wang's work include Breast Cancer Treatment Studies (6 papers), Cancer, Hypoxia, and Metabolism (5 papers) and HER2/EGFR in Cancer Research (3 papers). Mengshen Wang is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Cancer, Hypoxia, and Metabolism (5 papers) and HER2/EGFR in Cancer Research (3 papers). Mengshen Wang collaborates with scholars based in China. Mengshen Wang's co-authors include Xinyan Li, Litong Yao, Mozhi Wang, Haoran Dong, Xiangyu Sun, Tie Sun, Xueting Yu, Jingyi Guo, Yingying Xu and Yingying Xu and has published in prestigious journals such as Theranostics, Redox Biology and Cancer Science.

In The Last Decade

Mengshen Wang

18 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengshen Wang China 9 314 271 118 48 37 18 492
Chee Wai Fhu Singapore 8 300 1.0× 228 0.8× 95 0.8× 60 1.3× 14 0.4× 8 478
Yong Cheng China 11 287 0.9× 269 1.0× 211 1.8× 72 1.5× 17 0.5× 18 532
Zijia Sun China 11 281 0.9× 143 0.5× 215 1.8× 87 1.8× 24 0.6× 14 522
Mozhi Wang China 10 219 0.7× 194 0.7× 125 1.1× 41 0.9× 13 0.4× 24 395
Aristeidis E. Boukouris Canada 8 331 1.1× 129 0.5× 99 0.8× 38 0.8× 32 0.9× 13 493
Frédérique Fallone France 10 316 1.0× 223 0.8× 185 1.6× 41 0.9× 23 0.6× 12 574
Marcela Sosa‐Garrocho Mexico 12 341 1.1× 170 0.6× 77 0.7× 25 0.5× 16 0.4× 23 507
Dongdong Zhou China 12 210 0.7× 146 0.5× 99 0.8× 46 1.0× 13 0.4× 29 389
Ziping Wu China 11 182 0.6× 196 0.7× 103 0.9× 120 2.5× 17 0.5× 19 383
Tian Ma China 13 266 0.8× 132 0.5× 104 0.9× 67 1.4× 13 0.4× 36 498

Countries citing papers authored by Mengshen Wang

Since Specialization
Citations

This map shows the geographic impact of Mengshen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengshen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengshen Wang more than expected).

Fields of papers citing papers by Mengshen Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengshen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengshen Wang. The network helps show where Mengshen Wang may publish in the future.

Co-authorship network of co-authors of Mengshen Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Mengshen Wang. A scholar is included among the top collaborators of Mengshen Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengshen Wang. Mengshen Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Dong, Haoran, et al.. (2024). ACSL3 regulates breast cancer progression via lipid metabolism reprogramming and the YES1/YAP axis. Cancer Biology and Medicine. 21(7). 1–30. 7 indexed citations
2.
Wang, Yiou, Yue Hu, Mozhi Wang, Mengshen Wang, & Yingying Xu. (2024). The Role of Breast Cancer Cells in Bone Metastasis: Suitable Seeds for Nourishing Soil. Current Osteoporosis Reports. 22(1). 28–43. 5 indexed citations
3.
Ding, Wei, et al.. (2024). IBSP Promotes Breast Cancer Bone Metastasis and Proliferation via BMP‐SMAD Signaling Pathway. Cancer Reports. 7(8). e2153–e2153. 1 indexed citations
4.
Yao, Litong, Mozhi Wang, Mengshen Wang, et al.. (2021). The choice of a neoadjuvant chemotherapy cycle for breast cancer has significance in clinical practice: results from a population-based, real world study. Cancer Biology and Medicine. 19(5). 755–767. 6 indexed citations
5.
Yao, Litong, Shuang Li, Mengshen Wang, et al.. (2021). An Immune Model to Predict Prognosis of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy Based on Support Vector Machine. Frontiers in Oncology. 11. 651809–651809. 4 indexed citations
6.
Chen, Yuqiong, Li Su, Yan Zhang, et al.. (2021). The lncRNA Malat1 regulates microvascular function after myocardial infarction in mice via miR-26b-5p/Mfn1 axis-mediated mitochondrial dynamics. Redox Biology. 41. 101910–101910. 115 indexed citations
7.
Wang, Mengshen, Mozhi Wang, Zhenning Wang, et al.. (2021). Comparison of three lymph node staging methods for predicting outcome in breast cancer patients with mastectomy. Annals of Translational Medicine. 9(4). 300–300. 3 indexed citations
8.
Li, Xinyan, Mengshen Wang, Su Li, et al.. (2021). HIF-1-induced mitochondrial ribosome protein L52: a mechanism for breast cancer cellular adaptation and metastatic initiation in response to hypoxia. Theranostics. 11(15). 7337–7359. 44 indexed citations
9.
Li, Xinyan, Litong Yao, Mozhi Wang, et al.. (2020). Updated Bayesian Network Meta-Analysis of Adjuvant Targeted Treatment Regimens for Early Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer. Journal of Breast Cancer. 23(4). 410–410. 1 indexed citations
10.
Sun, Xiangyu, Mozhi Wang, Mengshen Wang, et al.. (2020). Metabolic Reprogramming in Triple-Negative Breast Cancer. Frontiers in Oncology. 10. 428–428. 156 indexed citations
11.
Sun, Xiangyu, Mozhi Wang, Mengshen Wang, et al.. (2020). Role of Proton-Coupled Monocarboxylate Transporters in Cancer: From Metabolic Crosstalk to Therapeutic Potential. Frontiers in Cell and Developmental Biology. 8. 651–651. 53 indexed citations
12.
Wang, Mengshen, Mozhi Wang, Zhenning Wang, et al.. (2020). Nomogram for predicting axillary lymph node status after neoadjuvant chemotherapy in breast cancer. Translational Cancer Research. 9(11). 7054–7064. 3 indexed citations
13.
Sun, Xiangyu, Mozhi Wang, Mengshen Wang, et al.. (2020). Exploring the Metabolic Vulnerabilities of Epithelial–Mesenchymal Transition in Breast Cancer. Frontiers in Cell and Developmental Biology. 8. 655–655. 21 indexed citations
14.
Dong, Haoran, Litong Yao, Mozhi Wang, et al.. (2020). Can ACEI/ARB prevent the cardiotoxicity caused by chemotherapy in early-stage breast cancer?—a meta-analysis of randomized controlled trials. Translational Cancer Research. 9(11). 7034–7043. 12 indexed citations
15.
Guo, Jingyi, Mozhi Wang, Mengshen Wang, et al.. (2019). The Undervalued Effects of Polychlorinated Biphenyl Exposure on Breast Cancer. Clinical Breast Cancer. 20(1). 12–18. 18 indexed citations
16.
Yao, Litong, Mozhi Wang, Mengshen Wang, et al.. (2019). Neoadjuvant endocrine therapy: A potential strategy for ER-positive breast cancer. World Journal of Clinical Cases. 7(15). 1937–1953. 6 indexed citations
17.
Li, Xinyan, Mozhi Wang, Mengshen Wang, et al.. (2019). Predictive and Prognostic Roles of Pathological Indicators for Patients with Breast Cancer on Neoadjuvant Chemotherapy. Journal of Breast Cancer. 22(4). 497–497. 21 indexed citations
18.
Wang, Mozhi, Mengshen Wang, Zhenning Wang, et al.. (2018). Long non‐coding RNA‐CTD‐2108O9.1 represses breast cancer metastasis by influencing leukemia inhibitory factor receptor. Cancer Science. 109(6). 1764–1774. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chee Wai Fhu Breakdown of academic impact, for papers by Yong Cheng Breakdown of academic impact, for papers by Zijia Sun Breakdown of academic impact, for papers by Mozhi Wang Breakdown of academic impact, for papers by Aristeidis E. Boukouris Breakdown of academic impact, for papers by Frédérique Fallone Breakdown of academic impact, for papers by Marcela Sosa‐Garrocho Breakdown of academic impact, for papers by Dongdong Zhou Breakdown of academic impact, for papers by Ziping Wu Breakdown of academic impact, for papers by Tian Ma
Rankless by CCL
2026